There was an adverse relationship between ING5 mRNA expression and the overall or progression-free survival of the ovarian cancer patients with stage I, Grade 3, and Grade 2, indicating the prognostic significance of ING5 depends on the cancer type, subtyping and molecular level (Zheng et al., 2017). This evidence concerns the gene ING5 and ovarian carcinoma.